vimarsana.com


Genedata Provides First End-to-End Multi-Attribute Method Solution for Characterization and Quality Monitoring of Biopharmaceuticals
Share Article
Latest release of Genedata Expressionist automates mass spectrometry processes and addresses key biopharma industry requirements for every stage of the MAM workflow
The end-to-end MAM solution provided by Genedata Expressionist 15.0 is a further demonstration of Genedata’s focus on addressing major bottlenecks from Research and Development to QC in close collaboration with our rapidly growing customer base in the biopharma industry.
BASEL, Switzerland (PRWEB)
March 11, 2021
Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of Genedata Expressionist® 15.0, the latest version of the only enterprise platform for streamlining and automating mass spectrometry-based workflows across instruments and analytical processes employed during biopharma R&D.

Related Keywords

Germany ,Japan ,United Kingdom ,Switzerland ,Singapore ,Helena Bonin ,Othmar Pfannes ,Development To Manufacturing ,Genedata Expressionist ,Extracted Ion Chromatogram ,Critical Quality Attribute ,Press Release ,ஜெர்மனி ,ஜப்பான் ,ஒன்றுபட்டது கிஂக்டம் ,சுவிட்சர்லாந்து ,சிங்கப்பூர் ,ஹெலினா போனின் ,வளர்ச்சி க்கு உற்பத்தி ,முக்கியமான தரம் பண்புக்கூறு ,ப்ரெஸ் வெளியீடு ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.